Biotechnology Podcasts This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

TWIV 236: Flu gets the VIP treatment
Hosts: Vincent Racaniello, Alan Dove, and Kathy Spindler Vincent, Alan and Kathy review novel approaches to preventing influenza virus infection. Links for this episode: Ultraprotective influenza vaccine in mice (PNAS) Vectored immunoprophylaxis of influenza in mice (Nat Biotech) Intranasal antibody gene transfer protects agains influenza (Sci Transl Med) Estimating influenza associated deaths (CDC) Multistate HAV outbreak (CDC) Subscribe to Microbeworld video (YouTube) Save podcasting (EFF) Letters read on TWiV 236 Weekly Science Picks Alan - Psy...
Source: This Week in Virology - MP3 Edition - June 9, 2013 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

TWiV 211: Viruses r us
Hosts: Vincent Racaniello, Rich Condit, Alan Dove, and Kathy Spindler The TWiV four discuss an mRNA-based influenza vaccine, and a phage tubulin that forms a filamentous array in the host cell that is needed for positioning viral DNA. Links for this episode: mRNA vaccine against influenza (Nat Biotech) Phage tubulin assembles dynamic filaments (Cell) Viral skeleton (The Scientist) Not unorganized bags of enzymes (TWiM 28) Bacterial cytoskeleton (FEMS Micro Rev) Triangulation number (jpg) Letters read on TWiV 211 Weekly Science Picks Rich - Ocean Global...
Source: This Week in Virology - MP3 Edition - December 16, 2012 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

An Introduction to Clinical Professionals
Clinical Professionals was founded in 2006, and is now a leading European pharmaceutical recruitment company, provide specialist recruitment services to biotechnology, pharmaceutical, devices and CRO ... Author: onlymedics Added: 11/26/2012 (Source: Oncology Tube)
Source: Oncology Tube - November 26, 2012 Category: Cancer & Oncology Source Type: podcasts

An Introduction to Clinical Professionals
Clinical Professionals was founded in 2006, and is now a leading European pharmaceutical recruitment company, provide specialist recruitment services to biotechnology, pharmaceutical, devices and CRO ... Author: clinicalprofessionals Added: 11/26/2012 (Source: Oncology Tube)
Source: Oncology Tube - November 26, 2012 Category: Cancer & Oncology Source Type: podcasts

TWiV 187: The mummy
Hosts: Vincent Racaniello and Rich Condit Vincent and Rich discuss recovery of a hepatitis B viral genome from a 16th century Korean mummy, and personal omics profiling of an individual over a 14 month period. Links for this episode: Tracing HBV to the 16th century (Hepatology) HBV on TWiV Precautions with ancient DNA (Science) Personal omics profile over 14 months (Cell) A geneticist's research turns personal (NY Times) Mike Snyder on Futures in Biotech The DASH diet TWiV on Facebook Letters read on TWiV 187 Weekly Science Picks Rich - The Checklist b...
Source: This Week in Virology - MP3 Edition - June 10, 2012 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

The Ellis Martin Report: Interview with International Stem Cell Corporation’s Founder/Co-Chairman
TEMR: Welcome to The Ellis Martin Report. I’m Bob Lange. We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO. International Stem Cell Corporation has been one of the most exciting companies trading in the biotech sector with respect to non-embryonic stem cell development. They have a proprietary process and commercial products that give them a tremendous edge in the marketplace. Ken welcome back to the show. I understand there’s a lot going on at International Stem Cell Corporation. Can you give us at least a portion...
Source: International Stem Cell Corporation - October 21, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology stem cell international stem cell corporation cosmeceutical Lifeline Cell Technology Lifeline Skin Care stem cell reagent stem cell skin care Source Type: podcasts

The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.
Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I have the pleasure of interviewing Executive Chairman, Kenneth Aldrich. International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regene...
Source: International Stem Cell Corporation - August 8, 2011 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell stem cell bank pluripotent international stem cell corporation parkinsons Source Type: podcasts

JHU Center for Biotechnology Education - 6th Annual Symposium
http://biotechnology.jhu.ed... "Molecular target identification for translational medicine: the anticancer topoisomerase I inhibitors." The John Hopkins University's Center for Biotechnolo... Author: feeds Added: 05/24/2011 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2011 Category: Cancer & Oncology Source Type: podcasts

TWiV #131 - A REOstat for cancer
Vincent, Alan, and Dickson chat with Brad Thompson, CEO of Oncolytics Biotech, about using reovirus to treat cancer. (Source: This Week in Virology - MP3 Edition)
Source: This Week in Virology - MP3 Edition - May 1, 2011 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Dr Alexander Kamb - Executive Director Oncology for Amgen
Alexander received his AB from Harvard University and his PhD from Caltech. After a postdoctoral fellowship at UCSF, he worked in the biotechnology field for about ten years, specializing in the genet... Author: feeds Added: 04/16/2011 (Source: Oncology Tube)
Source: Oncology Tube - April 16, 2011 Category: Cancer & Oncology Source Type: podcasts

TWiV #125 - TWiV infects FiB
This Week in Virology and Futures in Biotech join together in a science mashup to talk about a virophage at the origin of DNA transposons, and unintended spread of a recombinant retrovirus. (Source: This Week in Virology - MP3 Edition)
Source: This Week in Virology - MP3 Edition - March 21, 2011 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Bill Trombetta 2009 Industry Audit (Part 1)
Bill Trombetta explains changes in key evaluation metrics for this year’s survey as well as the implications of adding 11 new companies to the list, making it reflective of the emergence of generics, biotech and specialty firms as key competitors to traditional big pharma. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - November 1, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

The Difference Between Adult Stem Cells and Embryonic Stem Cells
This is Ken Aldrich. I am Chairman of International Stem Cell Corporation and thought I’d talk for just a minute, or maybe a couple of minutes, about the different kinds of stem cells. People are always asking, “What’s the difference between an adult stem cell and an embryonic stem cell?” Let me try to make this as simple as possible. Adult stem cells are those that are derived from the human body any time after the first, probably, week or two of development of the fetus in the womb. So, cells that come from cord blood, or cells that come from embryonic tissue as well as cells that come from an adult hum...
Source: International Stem Cell Corporation - April 16, 2009 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology health medicine parthenogenesis stem cell bank pluripotent international stem cell corporation alzheimers parkinsons leukemia vectors Source Type: podcasts

International Stem Cell Corporation Offers a Possible Alternative to Animal Corneal Testing
Please take a moment to listen to International Stem Cell Corporation Chairman, Ken Aldrich, as he discusses the benefits of using human corneas developed in Petri dishes as an alternative to testing on the eyes of innocent rabbits. This is Ken Aldrich and I am chairman of International Stem Cell Corporation and I am here to talk to you a little bit about rabbits. One of the things that most people don’t know is that cosmetic companies, drug companies and pesticide makers all have to test their products to see whether they do damage to the human eye. Unfortunately, the way they do it is to take poor innocent rabbi...
Source: International Stem Cell Corporation - April 16, 2009 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell animal testing human cornea Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Video Podcast- Part 3Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Video Podcast- Part 2Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Video Podcast- Part 1Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Audio Podcast- Part 3Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Audio Podcast- Part 2Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Public Consultation Meeting of the National Science Advisory Board for Biosecurity (NSABB) Personnel Reliability Working Group
Enhanced Audio Podcast- Part 1Presented by: Sponsored by the NIH Office of Biotechnology ActivitiesAired date: 4/9/2009 2:54:00 PM Eastern Time (Source: Videocast Podcasts)
Source: Videocast Podcasts - April 15, 2009 Category: Journals (General) Authors: National Institutes of Health Tags: Health Source Type: podcasts

Bill Trombetta Industry Audit (Part 4)
Genentech: Another permanent resident on the Top Four list, Genentech turns in mind-bending numbers. The big question: can Genentech keep it up. Bill Trombetta looks at the original biotech's remarkable successes and its challenges. (Source: Pharm Exec Podcast Interviews)
Source: Pharm Exec Podcast Interviews - December 15, 2008 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts

TWiV #10 - Bats, elephants, and AIDS
Vincent, DIck, and Alan chat about reconstruction of a bat SARS-like coronavirus, herpesviruses that are killing elephants in zoos, and a plan to eradicate AIDS in ten years. Links for this episode: The Virology Network at socialmedian.com. The bat SARS-like coronavirus: scientific article in PNAS, and the Wired Science article. NY Times Editorial on eradicating AIDS. Herpesviruses killing elephants. Science podcast pick of the week: Futures in Biotech. Science book of the week: Principles of Molecular Virology, by AJ Cann. (Source: This Week in Vi...
Source: This Week in Virology - MP3 Edition - December 4, 2008 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborator...
Source: International Stem Cell Corporation - November 24, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts

International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network. “To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world is a wonderful opportunity for ISCO. This partnership will lead to a significant expansion in ISCO’s revenue generation through the manufacture of high quality cells and cell culture products. Millipore is a leader in the life science industry, with a strong...
Source: International Stem Cell Corporation - September 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts

International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occurred. The investor ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts

A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts

Kenneth Aldrich is Interviewed on WallSt.Net.
Listen to an Interview of International Stem Cell Corporations CEO and Co Founder Kenneth Aldrich on Wallst.net http://www.wallst.net/audio/audio.asp?ticker=ISCO&id=4392 (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - January 24, 2008 Category: Stem Cells Authors: internationalstemcell Tags: Uncategorized biotechnology science health medicine Source Type: podcasts

Meet Ken Aldrich the co-founder of International Stem Cell Corporation
Welcome to this podcast. I am Ken Aldrich, Chairman and co-founder of International Stem Cell Corporation. International Stem Cell Corporation recently announced that our scientific team, led by our Chief Scientist, Dr. Elena Revazova, has created a new class of human stem cell lines that do not involve the use of fertilized eggs and may enable hundreds of millions of people of different sex, ages and racial groups to benefit from cell based therapy with cells that will not be rejected by the patients own immune system after transplanting. The article was published in the on line edition of the well known peer-review publi...
Source: International Stem Cell Corporation - December 30, 2007 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts

Mean Genes: From Sex to Money to Food: Taming Our Primal Instincts
Deborah Harper, President of Psychjourney, interviews Dr. Terry Burnham, co-author of Mean Genes: From Sex to Money to Food: Taming Our Primal Instincts by Terry Burnham, Ph.D. and Jay Phelan, Ph.D. published by Penguin.Terry Burnham, Ph.D., is an economics professor at the Harvard Business School. He received his Ph.D. in Business Economics from Harvard in 1997, and has an MBA from MIT, a master in computer science, and a bachelor's in biophysics from the University of Michigan. Terry has worked on Wall Street and co-founded Progenics, a biotechnology firm with promising treatments for cancer and AIDS. Terry has ...
Source: Psychology and Self Help Books - May 16, 2007 Category: Psychiatrists and Psychologists Authors: Psychjourney Tags: Genetics Source Type: podcasts

Mean Genes: From Sex to Money to Food: Taming Our Primal Instincts
Deborah Harper, President of Psychjourney, interviews Dr. Terry Burnham, co-author of Mean Genes: From Sex to Money to Food: Taming Our Primal Instincts by Terry Burnham, Ph.D. and Jay Phelan, Ph.D. published by Penguin.Terry Burnham, Ph.D., is an economics professor at the Harvard Business School. He received his Ph.D. in Business Economics from Harvard in 1997, and has an MBA from MIT, a master in computer science, and a bachelor's in biophysics from the University of Michigan. Terry has worked on Wall Street and co-founded Progenics, a biotechnology firm with promising treatments for cancer and AIDS. Terry has studied w...
Source: Psychjourney Podcasts - May 16, 2007 Category: Psychiatrists and Psychologists Authors: Psychjourney Tags: Genetics Source Type: podcasts

The Intelligent Universe: AI, ET, and the Emerging Mind of the Cosmos
Kevin Keough, Psy.D., clinical psychologist and host of The Public Square interviews Attorney James Gardner, author of The Intelligent Universe: AI, ET, and the Emerging Mind of the Cosmos published by New Page Books. James Gardner, the author of The Intelligent Universe: AI, ET, and the Emerging Mind of the Cosmos, is a widely published science essayist and complexity theorist. His science essays and peer-reviewed scientific papers have appeared in Nature, Biotechnology, Wired, World Link (the scientific journal of the Santa Fe Institute), Acta Astronautica (the scientific journal of the International Acad...
Source: Psychjourney Podcasts - March 20, 2007 Category: Psychiatrists and Psychologists Authors: Deborah Harper Tags: Intelligent Universe Source Type: podcasts